簡介

本頁面提供了有關 Brian K Beeler 已知的內部交易歷史的全面分析。內部人士包括公司的高管、董事或重要投資者。一般而言,基於內幕、非公開信息進行交易是非法的。這並不意味著他們在自己的公司進行任何交易都是非法的。但是,他們必須透過Form 4向美國證券交易委員會(SEC)報告所有交易。盡管存在這些限制,學術研究表明,內部人士 - 整體而言 - 在自己公司中的投資表現往往優於市場。

平均交易盈利能力

「平均交易盈利能力」衡量了內部人士在過去三年中所有非計劃性的公開市場購買交易的平均回報率。計算過程包括檢查每筆交易,排除了作為10b5-1交易計劃的一部分的交易。然後,對每筆交易在3、6和12個月的表現進行平均,以生成該筆交易最終的表現指標。最終,將所有交易的表現指標進行平均,計算出內部人士的總體平均表現指標。列表僅包含在過去兩年中進行過至少三筆交易的內部人士。

如果內部人士的交易盈利能力顯示為"N/A",則可能是因為該內部人士在過去三年內沒有進行任何公開市場購買交易,或者他們進行的交易距離現在太近,無法計算出可靠的表現指標。

更新頻率:每日

查看收益最高的的內幕交易者列表。

報告內部持倉的公司

SEC文件顯示Brian K Beeler已報告在以下公司擁有持倉或進行了交易:

證券 職位 最新報告的持倉
US:HZNP / Horizon Therapeutics Plc EVP, General Counsel 62,775
如何解讀這些圖表

以下圖表顯示了在Brian K Beeler進行的每筆公開市場非計劃交易後證券的股價表現。非計劃交易是指沒有作為10b5-1交易計劃的一部分而進行的交易。股價表現以累積百分比變化的方式繪製。例如,如果一筆內部人士交易是在2019年1月1日進行的,該圖表將顯示該證券的每日百分比變化直至當前日期。如果在此期間股價從10美元漲至15美元,則股價的累積百分比變化將為50%。從10美元漲至20美元的價格變化將為100%,而從10美元跌至5美元的價格變化將為-50%。

最終,我們將評估內部人士的交易與股價的超額回報(正向或負向)之間的相關性,以判斷內部人士是否在交易中利用內部信息獲利。如果內部人士有這樣的行為,我們預期看到(a)購買後的正回報,或者(b)賣出後的負回報。對於情況(a),購買圖表將顯示一系列向上傾斜的曲線,表示每次購買後都有正回報。對於情況(b),賣出圖表將顯示一系列向下傾斜的曲線,表示每次賣出後都有負回報。

然而,僅憑這一點還不足以得出結論。例如,如果公司的股價在多年內呈現非周期性上升,我們會預期所有購買後的圖表都呈現向上傾斜。同樣地,多年來呈現非周期性下降的股價會導致賣出後的圖表也呈現向下傾斜。這兩種情況的圖表都不能表示內部人士在進行內幕交易。

最有力的指標是在公司股價呈極度循環波動的情況下,「購買」圖表顯示正向信號,而「賣出」圖表顯示負向趨勢。這種情況強烈暗示內部人士可能根據內幕信息精確地計時進行交易,以獲得財務優勢。

歷史內部人交易

該表格顯示了由 Brian K Beeler 進行的所有內幕交易的完整列表,這些交易已向美國證券交易委員會(SEC)披露。

呈報日期 交易日期 表格 證券代碼 證券 代碼 10b5-1 股份 剩餘股份 %
變化
每股
股價
交易
金額
剩餘
金額
2021-09-17 2021-09-17 4 HZNP Horizon Therapeutics Public Ltd Co
Ordinary Shares
S - Sale X -28,143 62,775 -30.95 107.91 -3,036,911 6,774,050
2021-08-17 2021-08-16 4 HZNP Horizon Therapeutics Public Ltd Co
Stock Option (Right to Buy)
M - Exercise -65,857 0 -100.00
2021-08-17 2021-08-16 4 HZNP Horizon Therapeutics Public Ltd Co
Ordinary Shares
S - Sale -74,898 90,918 -45.17 106.00 -7,939,188 9,637,308
2021-08-17 2021-08-16 4 HZNP Horizon Therapeutics Public Ltd Co
Ordinary Shares
M - Exercise 65,857 165,816 65.88 22.14 1,458,074 3,671,166
2021-07-30 2021-07-28 4 HZNP Horizon Therapeutics Public Ltd Co
Performance Restricted Stock Units (PSUs)
A - Award 11,612 11,612
2021-07-30 2021-07-28 4 HZNP Horizon Therapeutics Public Ltd Co
Ordinary Shares
F - Taxes -2,573 99,959 -2.51 102.50 -263,732 10,245,798
2021-07-30 2021-07-28 4 HZNP Horizon Therapeutics Public Ltd Co
Ordinary Shares
A - Award 5,806 102,532 6.00
2021-04-02 2021-03-31 4 HZNP Horizon Therapeutics Public Ltd Co
Ordinary Shares
S - Sale X -26,844 95,677 -21.91 90.12 -2,419,181 8,622,411
2021-02-19 2021-02-17 4 HZNP Horizon Therapeutics Public Ltd Co
Performance Restricted Stock Units (PSUs)
A - Award 11,610 11,610
2021-02-19 2021-02-17 4 HZNP Horizon Therapeutics Public Ltd Co
Performance Restricted Stock Units (PSUs)
A - Award 3,144 3,144
2021-02-19 2021-02-17 4 HZNP Horizon Therapeutics Public Ltd Co
Ordinary Shares
F - Taxes -696 122,521 -0.56 87.17 -60,670 10,680,156
2021-02-19 2021-02-17 4 HZNP Horizon Therapeutics Public Ltd Co
Ordinary Shares
A - Award 1,571 123,217 1.29
2021-01-22 2021-01-21 4 HZNP Horizon Therapeutics Public Ltd Co
Performance Restricted Stock Units (PSUs)
M - Exercise -4,120 4,120 -50.00
2021-01-22 2021-01-21 4 HZNP Horizon Therapeutics Public Ltd Co
Ordinary Shares
F - Taxes -1,826 121,646 -1.48 77.43 -141,387 9,419,050
2021-01-22 2021-01-21 4 HZNP Horizon Therapeutics Public Ltd Co
Ordinary Shares
M - Exercise 4,120 123,472 3.45
2021-01-06 2021-01-05 4 HZNP Horizon Therapeutics Public Ltd Co
Restricted Stock Units (RSU)
M - Exercise -9,675 19,352 -33.33
2021-01-06 2021-01-05 4 HZNP Horizon Therapeutics Public Ltd Co
Restricted Stock Units (RSU)
M - Exercise -17,260 0 -100.00
2021-01-06 2021-01-05 4 HZNP Horizon Therapeutics Public Ltd Co
Restricted Stock Units (RSU)
M - Exercise -12,261 12,261 -50.00
2021-01-06 2021-01-05 4 HZNP Horizon Therapeutics Public Ltd Co
Ordinary Shares
F - Taxes -44,185 119,352 -27.02 73.28 -3,237,877 8,746,115
2021-01-06 2021-01-05 4 HZNP Horizon Therapeutics Public Ltd Co
Ordinary Shares
A - Award 60,313 163,537 58.43
2021-01-06 2021-01-05 4 HZNP Horizon Therapeutics Public Ltd Co
Ordinary Shares
M - Exercise 39,196 103,224 61.22
2021-01-06 2021-01-04 4 HZNP Horizon Therapeutics Public Ltd Co
Restricted Stock Units (RSU)
A - Award 24,449 24,449
2020-09-08 2020-09-04 4 HZNP Horizon Therapeutics Public Ltd Co
Stock Option (Right to Buy)
M - Exercise -14,143 65,857 -17.68
2020-09-08 2020-09-04 4 HZNP Horizon Therapeutics Public Ltd Co
Stock Option (Right to Buy)
M - Exercise -14,000 0 -100.00
2020-09-08 2020-09-04 4 HZNP Horizon Therapeutics Public Ltd Co
Ordinary Shares
M - Exercise 14,143 64,028 28.35 22.14 313,126 1,417,580
2020-09-08 2020-09-04 4 HZNP Horizon Therapeutics Public Ltd Co
Ordinary Shares
M - Exercise 14,000 49,885 39.01 7.61 106,540 379,625
2020-06-02 2020-06-01 4 HZNP Horizon Therapeutics Public Ltd Co
Ordinary Shares
S - Sale X -2,370 35,885 -6.20 50.23 -119,045 1,802,504
2020-05-07 2020-05-06 4 HZNP Horizon Therapeutics Public Ltd Co
Ordinary Shares
S - Sale X -48,000 37,206 -56.33 40.80 -1,958,515 1,518,094
2020-04-30 2020-04-29 4 HZNP Horizon Therapeutics Public Ltd Co
Ordinary Shares
S - Sale X -15,880 85,206 -15.71 35.02 -556,118 2,983,914
2020-04-17 2020-04-16 4 HZNP Horizon Therapeutics Public Ltd Co
Ordinary Shares
S - Sale X -9,000 101,086 -8.18 32.51 -292,615 3,286,589
2020-04-08 2020-04-07 4 HZNP Horizon Therapeutics Public Ltd Co
Ordinary Shares
S - Sale X -297 110,086 -0.27 32.50 -9,652 3,577,795
2020-04-08 2020-04-06 4 HZNP Horizon Therapeutics Public Ltd Co
Ordinary Shares
S - Sale X -2,370 110,383 -2.10 32.50 -77,025 3,587,448
2020-02-21 2020-02-19 4 HZNP Horizon Therapeutics Public Ltd Co
Performance Restricted Stock Units (PSUs)
A - Award 20,465 20,465
2020-02-21 2020-02-19 4 HZNP Horizon Therapeutics Public Ltd Co
Ordinary Shares
F - Taxes -4,534 112,753 -3.87 36.06 -163,496 4,065,873
2020-02-21 2020-02-19 4 HZNP Horizon Therapeutics Public Ltd Co
Ordinary Shares
A - Award 10,232 117,287 9.56
2020-02-21 2020-01-21 4/A HZNP Horizon Therapeutics Public Ltd Co
Performance Restricted Stock Units (PSUs)
A - Award 8,240 8,240
2020-02-21 2020-01-21 4/A HZNP Horizon Therapeutics Public Ltd Co
Ordinary Shares
F - Taxes -1,825 107,055 -1.68 38.25 -69,806 4,094,854
2020-02-21 2020-01-21 4/A HZNP Horizon Therapeutics Public Ltd Co
Ordinary Shares
A - Award 4,119 108,880 3.93
2020-01-23 2020-01-21 4 HZNP Horizon Therapeutics Public Ltd Co
Performance Restricted Stock Units (PSUs)
A - Award 9,810 9,810
2020-01-23 2020-01-21 4 HZNP Horizon Therapeutics Public Ltd Co
Ordinary Shares
F - Taxes -2,173 107,491 -1.98 38.25 -83,117 4,111,531
2020-01-23 2020-01-21 4 HZNP Horizon Therapeutics Public Ltd Co
Ordinary Shares
A - Award 4,903 109,664 4.68
2020-01-07 2020-01-05 4 HZNP Horizon Therapeutics Public Ltd Co
Restricted Stock Units (RSU)
M - Exercise -17,260 17,260 -50.00
2020-01-07 2020-01-05 4 HZNP Horizon Therapeutics Public Ltd Co
Restricted Stock Units (RSU)
M - Exercise -12,260 24,522 -33.33
2020-01-07 2020-01-05 4 HZNP Horizon Therapeutics Public Ltd Co
Ordinary Shares
F - Taxes -21,690 104,761 -17.15 36.10 -783,009 3,781,872
2020-01-07 2020-01-05 4 HZNP Horizon Therapeutics Public Ltd Co
Ordinary Shares
A - Award 19,014 126,451 17.70
2020-01-07 2020-01-05 4 HZNP Horizon Therapeutics Public Ltd Co
Ordinary Shares
M - Exercise 29,520 107,437 37.89
2020-01-07 2020-01-03 4 HZNP Horizon Therapeutics Public Ltd Co
Restricted Stock Units (RSU)
A - Award 29,027 29,027
2019-12-20 2019-12-18 4 HZNP Horizon Therapeutics Public Ltd Co
Ordinary Shares
S - Sale X -6,716 77,917 -7.94 35.00 -235,060 2,727,095
2019-11-27 2019-11-25 4 HZNP Horizon Therapeutics Public Ltd Co
Ordinary Shares
S - Sale X -5,000 84,633 -5.58 32.52 -162,600 2,752,265
2019-11-27 2019-11-25 4 HZNP Horizon Therapeutics Public Ltd Co
Ordinary Shares
S - Sale X -4,969 89,633 -5.25 32.50 -161,492 2,913,072
2019-11-07 2019-11-05 4 HZNP Horizon Therapeutics Public Ltd Co
Ordinary Shares
S - Sale X -8,775 94,602 -8.49 30.02 -263,462 2,840,349
2019-11-07 2019-11-05 4 HZNP Horizon Therapeutics Public Ltd Co
Ordinary Shares
S - Sale X -3,700 103,377 -3.46 30.00 -111,000 3,101,310
2019-03-25 2019-03-23 4 HZNP Horizon Pharma plc
Restricted Stock Units
M - Exercise -9,500 0 -100.00
2019-03-25 2019-03-23 4 HZNP Horizon Pharma plc
Ordinary Shares
F - Taxes -4,209 104,707 -3.86 26.84 -112,970 2,810,336
2019-03-25 2019-03-23 4 HZNP Horizon Pharma plc
Ordinary Shares
M - Exercise 9,500 108,916 9.56
2019-02-22 2019-02-20 4 HZNP Horizon Pharma plc
Ordinary Shares
F - Taxes -8,425 99,416 -7.81 21.54 -181,474 2,141,421
2019-02-22 2019-02-20 4 HZNP Horizon Pharma plc
Ordinary Shares
A - Award 19,014 107,841 21.41
2019-01-08 2019-01-05 4 HZNP Horizon Pharma plc
Restricted Stock Units (RSU)
M - Exercise -17,259 34,520 -33.33
2019-01-08 2019-01-05 4 HZNP Horizon Pharma plc
Ordinary Shares
F - Taxes -7,962 88,827 -8.23 20.39 -162,345 1,811,183
2019-01-08 2019-01-05 4 HZNP Horizon Pharma plc
Ordinary Shares
M - Exercise 17,259 96,789 21.70
2019-01-08 2019-01-04 4 HZNP Horizon Pharma plc
Restricted Stock Units (RSU)
A - Award 36,782 36,782
2018-06-12 2018-06-08 4 HZNP Horizon Pharma plc
Ordinary Shares
S - Sale X -8,888 79,530 -10.05 18.00 -159,984 1,431,540
2018-06-12 2018-06-08 4 HZNP Horizon Pharma plc
Ordinary Shares
S - Sale X -6,545 88,418 -6.89 17.00 -111,265 1,503,106
2018-05-30 2018-05-25 4 HZNP Horizon Pharma plc
Stock Option (Right to Buy)
M - Exercise -48,000 0 -100.00
2018-05-30 2018-05-25 4 HZNP Horizon Pharma plc
Ordinary Shares
S - Sale -17,931 92,593 -16.22 16.11 -288,868 1,491,673
2018-05-30 2018-05-25 4 HZNP Horizon Pharma plc
Ordinary Shares
M - Exercise 48,000 110,524 76.77 2.40 115,200 265,258
2018-05-07 2018-05-03 4 HZNP Horizon Pharma plc
Restricted Stock Units (RSU)
A - Award 51,779 51,779
2018-03-27 2018-03-23 4 HZNP Horizon Pharma plc
Restricted Stock Units
M - Exercise -9,500 9,500 -50.00
2018-03-27 2018-03-23 4 HZNP Horizon Pharma plc
Ordinary Shares
F - Taxes -2,784 62,524 -4.26 13.86 -38,586 866,583
2018-03-27 2018-03-23 4 HZNP Horizon Pharma plc
Ordinary Shares
M - Exercise 9,500 65,308 17.02
2018-01-03 2018-01-02 4 HZNP Horizon Pharma plc
Restricted Stock Units
M - Exercise -3,200 0 -100.00
2018-01-03 2018-01-02 4 HZNP Horizon Pharma plc
Ordinary Shares
F - Taxes -1,204 55,808 -2.11 15.02 -18,084 838,236
2018-01-03 2018-01-02 4 HZNP Horizon Pharma plc
Ordinary Shares
M - Exercise 3,200 57,012 5.95
2017-03-24 2017-03-23 4 HZNP Horizon Pharma plc
Restricted Stock Units
M - Exercise -9,500 19,000 -33.33
2017-03-24 2017-03-23 4 HZNP Horizon Pharma plc
Ordinary Shares
F - Taxes -2,955 52,383 -5.34 14.56 -43,025 762,696
2017-03-24 2017-03-23 4 HZNP Horizon Pharma plc
Ordinary Shares
M - Exercise 9,500 55,338 20.73
2017-01-04 2017-01-02 4 HZNP Horizon Pharma plc
Restricted Stock Units
M - Exercise -3,200 3,200 -50.00
2017-01-04 2017-01-02 4 HZNP Horizon Pharma plc
Restricted Stock Units
M - Exercise -8,000 0 -100.00
2017-01-04 2017-01-02 4 HZNP Horizon Pharma plc
Ordinary Shares
F - Taxes -3,871 45,838 -7.79 16.18 -62,633 741,659
2017-01-04 2017-01-02 4 HZNP Horizon Pharma plc
Ordinary Shares
M - Exercise 11,200 49,709 29.08
2016-03-24 2016-03-23 4 HZNP Horizon Pharma plc
Restricted Stock Units
M - Exercise -9,500 28,500 -25.00
2016-03-24 2016-03-23 4 HZNP Horizon Pharma plc
Ordinary Shares
F - Taxes -2,955 37,081 -7.38 16.32 -48,226 605,162
2016-03-24 2016-03-23 4 HZNP Horizon Pharma plc
Ordinary Shares
M - Exercise 9,500 40,036 31.11
2016-03-02 3/A HZNP Horizon Pharma plc
Ordinary Shares
19,377
2016-01-05 2016-01-02 4 HZNP Horizon Pharma plc
Restricted Stock Units
M - Exercise -3,200 6,400 -33.33
2016-01-05 2016-01-02 4 HZNP Horizon Pharma plc
Restricted Stock Units
M - Exercise -8,000 8,000 -50.00
2016-01-05 2016-01-02 4 HZNP Horizon Pharma plc
Ordinary Shares
F - Taxes -3,741 26,402 -12.41 21.67 -81,067 572,131
2016-01-05 2016-01-02 4 HZNP Horizon Pharma plc
Ordinary Shares
M - Exercise 11,200 30,143 59.12
2015-05-08 2015-05-06 4 HZNP Horizon Pharma plc
Performance Share Units (PSU)
A - Award 558,000 558,000
2015-05-08 2015-05-06 4 HZNP Horizon Pharma plc
Performance Share Units (PSU)
A - Award 153,000 153,000
2015-05-08 3 HZNP Horizon Pharma plc
Ordinary Shares
30,486
2015-05-08 3 HZNP Horizon Pharma plc
Ordinary Shares
30,486
P
非衍生或衍生證券的公開市場或私下買入
S
非衍生或衍生證券的公開市場或私下賣出
A
公司向內部人員授予、獎勵或以其他方式獲取證券(例如股票期權)
C
衍生工具轉換
D
將證券賣出或轉讓回公司
F
使用從公司收到的證券的一部分來支付行使價或稅務負擔。
G
內部人士贈送或接收他人贈送公司股票
K
股權掉期和類似的避險交易
M
行使或轉換從公司獲得的衍生證券(例如期權)
V
內部人士透過Form 4自願報告的一筆交易
J
其他(附有交易描述的腳註)